Medeor Pharma Pvt Ltd, a active private limited company, was established on 03 March 1983 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51909WB1983PTC035981. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹4.30 M and a paid-up capital of ₹4.27 M.
It upholds a compliant status. Employing 22 professional, Its leadership includes Bratati Sinha Ray (Additional Director), Arup Das (Director), Bibek Roy (Director). Past directors included Lalima Das, Jonaki Banerjee, Samir Debmajumdar. It holds ₹2.58 Cr open charges and ₹9.30 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 389/4 Jessore Road, Kolkata, West Bengal, 700055.
U51909WB1983PTC035981
035981
03 March 1983
₹4.30 M
₹4.27 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Medeor Pharma Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bratati Sinha Ray | Additional Director | 06 Aug 2024 | Current |
| Arup Das | Director | 16 Dec 1996 | Current |
| Bibek Roy | Director | 24 Dec 1996 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2018 | Past |
| Pramod Abcsdd | Director | 06 Aug 2024 | Past |
| Pramod Abcsdd | Director | 22 Sep 2010 | Past |
| Pramod Abcsdd | Director | 28 Oct 2022 | Past |
| Pramod Abcsdd | Director | 06 Aug 2024 | Past |
| Pramod Abcsdd | Managing Director | 30 Jun 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medeor Pharma Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 7.02% increase. The company also saw a substantial improvement in profitability, with a 1593.86% increase in profit. The company's net worth moved up by a moderate rise of 1.83%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Medeor Pharma had a public holding of 20.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹25,849,000.00
₹9,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2010 | Indian Bank | ₹2.49 Cr | Open |
| 17 Mar 2005 | State Bank Of India | ₹0.90 M | Open |
| 20 Apr 2007 | Punjab National Bank | ₹0.30 M | Satisfied |
| 31 Mar 2006 | Punjab National Bank | ₹7.00 M | Satisfied |
| 31 Mar 2006 | Punjab National Bank | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Medeor Pharma has a workforce of 22 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medeor Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medeor Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medeor Pharma Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Bratati Sinha Ray was appointed as a Additional Director was appointed as a Additional Director on 06 Aug 2024 & has been associated with this company since 1 year 4 months . was documented.
Progress on Medeor Pharma Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was documented.
The activity A charge with Indian Bank of Rs. 24.95 M registered on 29 Sep 2010 with Charge ID 10248491 was modified on 19 Feb 2022. was completed.
The activity A charge registered on 20 Apr 2007 via Charge ID 10055000 with Punjab National Bank was fully satisfied on 07 Mar 2012. was completed.
Progress on A charge registered on 31 Mar 2006 via Charge ID 80027710 with Punjab National Bank was fully satisfied on 07 Mar 2012. was documented.
The CIN of Medeor Pharma Pvt Ltd is U51909WB1983PTC035981.
Medeor Pharma Pvt Ltd is headquartered at 389/4 Jessore Road, Kolkata, West Bengal, 700055.
Medeor Pharma Pvt Ltd was incorporated on 03 March 1983.
The current directors of Medeor Pharma Pvt Ltd are
The primary industry of Medeor Pharma Pvt Ltd is Manufacturing.
Medeor Pharma Pvt Ltd is unlisted.
The authorized capital of Medeor Pharma Pvt Ltd is ₹4.30 M, and the paid-up capital is ₹4.27 M.
The compliance status of Medeor Pharma Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX